Risks	O
and	O
benefits	O
of	O
reducing	O
target	O
volume	O
margins	B:C0229985
in	O
breast	O
tangent	I:C0948310
radiotherapy	I:C0948310
.	O

Risks	O
and	O
benefits	O
of	O
reducing	O
target	O
volume	O
margins	O
in	O
breast	B:C0948310
tangent	I:C0948310
radiotherapy	I:C0948310
.	O

This	O
study	O
investigates	O
the	O
potential	O
benefits	O
of	O
planning	O
target	O
volume	O
(	O
PTV	O
)	O
margin	B:C0229985
reduction	O
for	O
whole	O
breast	O
radiotherapy	I:C0948310
in	O
relation	O
to	O
dose	O
received	O
by	O
organs	O
at	I:C2936599
risk	I:C2936599
(	O
organs	O
at	I:C2936599
risk	I:C2936599
)	O
,	O
as	O
well	O
as	O
reductions	O
in	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
risk	O
.	O

This	O
study	O
investigates	O
the	O
potential	O
benefits	O
of	O
planning	O
target	O
volume	O
(	O
PTV	O
)	O
margin	O
reduction	O
for	O
whole	O
breast	B:C0948310
radiotherapy	I:C0948310
in	O
relation	O
to	O
dose	O
received	O
by	O
organs	O
at	I:C2936599
risk	I:C2936599
(	O
organs	O
at	I:C2936599
risk	I:C2936599
)	O
,	O
as	O
well	O
as	O
reductions	O
in	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
risk	O
.	O

This	O
study	O
investigates	O
the	O
potential	O
benefits	O
of	O
planning	O
target	O
volume	O
(	O
PTV	O
)	O
margin	O
reduction	O
for	O
whole	O
breast	O
radiotherapy	I:C0948310
in	O
relation	O
to	O
dose	O
received	O
by	O
organs	B:C2936599
at	I:C2936599
risk	I:C2936599
(	O
organs	O
at	I:C2936599
risk	I:C2936599
)	O
,	O
as	O
well	O
as	O
reductions	O
in	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
risk	O
.	O

This	O
study	O
investigates	O
the	O
potential	O
benefits	O
of	O
planning	O
target	O
volume	O
(	O
PTV	O
)	O
margin	O
reduction	O
for	O
whole	O
breast	O
radiotherapy	I:C0948310
in	O
relation	O
to	O
dose	O
received	O
by	O
organs	O
at	I:C2936599
risk	I:C2936599
(	O
organs	B:C2936599
at	I:C2936599
risk	I:C2936599
)	O
,	O
as	O
well	O
as	O
reductions	O
in	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
risk	O
.	O

Such	O
benefits	O
were	O
compared	O
to	O
the	O
increased	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
risk	O
attributed	O
from	O
increased	O
ionizing	B:C1514690
radiation	I:C1514690
imaging	I:C1514690
doses	O
.	O

Ten	O
retrospective	O
patients	O
'	O
computed	B:C0040405
tomography	I:C0040405
datasets	O
were	O
considered	O
.	O

Ten	O
retrospective	O
patients	O
'	O
computed	O
tomography	I:C0040405
datasets	B:C0150098
were	O
considered	O
.	O

Three	O
computerized	B:C0599880
treatment	I:C0599880
plans	I:C0599880
with	O
varied	O
PTV	O
margins	O
(	O
0	O
,	O
5	O
and	O
10	O
mm	O
)	O
were	O
created	O
for	O
each	O
patient	O
complying	O
with	O
the	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
(	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
)	O
1005	O
protocol	O
requirements	O
.	O

Three	O
computerized	O
treatment	I:C0599880
plans	I:C0599880
with	O
varied	O
PTV	O
margins	B:C0229985
(	O
0	O
,	O
5	O
and	O
10	O
mm	O
)	O
were	O
created	O
for	O
each	O
patient	O
complying	O
with	O
the	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
(	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
)	O
1005	O
protocol	O
requirements	O
.	O

Three	O
computerized	O
treatment	I:C0599880
plans	I:C0599880
with	O
varied	O
PTV	O
margins	O
(	O
0	O
,	O
5	O
and	O
10	O
mm	O
)	O
were	O
created	O
for	O
each	O
patient	O
complying	O
with	O
the	O
Radiation	B:C1514695
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
(	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
)	O
1005	O
protocol	O
requirements	O
.	O

Three	O
computerized	O
treatment	I:C0599880
plans	I:C0599880
with	O
varied	O
PTV	O
margins	O
(	O
0	O
,	O
5	O
and	O
10	O
mm	O
)	O
were	O
created	O
for	O
each	O
patient	O
complying	O
with	O
the	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
(	O
Radiation	B:C1514695
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
)	O
1005	O
protocol	O
requirements	O
.	O

Three	O
computerized	O
treatment	I:C0599880
plans	I:C0599880
with	O
varied	O
PTV	O
margins	O
(	O
0	O
,	O
5	O
and	O
10	O
mm	O
)	O
were	O
created	O
for	O
each	O
patient	O
complying	O
with	O
the	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
(	O
Radiation	O
Therapy	I:C1514695
Oncology	I:C1514695
Group	I:C1514695
)	O
1005	O
protocol	B:C0442711
requirements	O
.	O

The	O
BEIR	O
VII	O
lifetime	O
attributable	O
risk	O
(	O
LAR	O
)	O
model	B:C3161035
was	O
used	O
to	O
estimate	O
secondary	O
cancer	O
risk	O
to	O
organs	O
at	I:C2936599
risk	I:C2936599
.	O

The	O
BEIR	O
VII	O
lifetime	O
attributable	O
risk	O
(	O
LAR	O
)	O
model	O
was	O
used	O
to	O
estimate	O
secondary	O
cancer	O
risk	O
to	O
organs	B:C2936599
at	I:C2936599
risk	I:C2936599
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	B:C0599880
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	O
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	B:C0229985
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	O
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	B:C3641875
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	O
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	B:C3641875
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	O
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	B:C0011923
protocols	O
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	B:C0442711
during	O
the	O
course	O
of	I:C3899630
treatment	I:C3899630
.	O

The	O
LAR	O
was	O
assessed	O
for	O
all	O
treatment	O
plans	I:C0599880
considering	O
(	O
a	O
)	O
doses	O
from	O
PTV	O
margin	O
variation	O
and	O
(	O
b	O
)	O
doses	O
from	O
two	O
(	O
daily	O
and	O
weekly	O
)	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
(	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
)	O
imaging	O
protocols	O
during	O
the	O
course	B:C3899630
of	I:C3899630
treatment	I:C3899630
.	O

We	O
found	O
PTV	O
margins	B:C0229985
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	B:C2936599
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	B:C0018787
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	B:C0024109
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	B:C0441988
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	B:C0006141
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	B:C0006826
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	B:C0441988
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	B:C0006141
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	B:C0441988
lung	O
)	O
.	O

We	O
found	O
PTV	O
margins	O
from	O
largest	O
to	O
smallest	O
resulted	O
in	O
a	O
mean	O
OAR	O
relative	O
dose	O
reduction	O
of	O
31	O
%	O
(	O
heart	O
)	O
,	O
28	O
%	O
(	O
lung	O
)	O
and	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
the	O
risk	O
of	O
radiation	O
-	O
induced	O
secondary	O
cancer	O
by	O
a	O
relative	O
23	O
%	O
(	O
contralateral	O
breast	O
)	O
and	O
22	O
%	O
(	O
contralateral	O
lung	B:C0024109
)	O
.	O

Daily	O
image	B:C0442972
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	O
breast	O
and	O
contralateral	O
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	B:C3641875
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	O
breast	O
and	O
contralateral	O
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	B:C0006826
to	O
the	O
contralateral	O
breast	O
and	O
contralateral	O
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	B:C0441988
breast	O
and	O
contralateral	O
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	O
breast	B:C0006141
and	O
contralateral	O
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	O
breast	O
and	O
contralateral	B:C0441988
lung	O
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Daily	O
image	O
-	I:C0442972
guidance	I:C0442972
using	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
increased	O
the	O
risk	O
of	O
radiation	O
induced	O
secondary	O
cancer	O
to	O
the	O
contralateral	O
breast	O
and	O
contralateral	O
lung	B:C0024109
by	O
a	O
relative	O
1.6-	O
1.9	O
%	O
and	O
1.9	O
-	O
2.5	O
%	O
respectively	O
.	O

Despite	O
the	O
additional	O
dose	O
from	O
kilovoltage	B:C3641875
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
for	O
the	O
two	O
considered	O
imaging	O
protocols	O
,	O
smaller	O
PTV	O
margins	O
would	O
still	O
result	O
in	O
an	O
overall	O
reduction	O
in	O
secondary	O
cancer	O
risk	O
.	O

Despite	O
the	O
additional	O
dose	O
from	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
for	O
the	O
two	O
considered	O
imaging	B:C0011923
protocols	O
,	O
smaller	O
PTV	O
margins	O
would	O
still	O
result	O
in	O
an	O
overall	O
reduction	O
in	O
secondary	O
cancer	O
risk	O
.	O

Despite	O
the	O
additional	O
dose	O
from	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
for	O
the	O
two	O
considered	O
imaging	O
protocols	B:C0442711
,	O
smaller	O
PTV	O
margins	O
would	O
still	O
result	O
in	O
an	O
overall	O
reduction	O
in	O
secondary	O
cancer	O
risk	O
.	O

Despite	O
the	O
additional	O
dose	O
from	O
kilovoltage	O
cone	I:C3641875
beam	I:C3641875
computed	I:C3641875
tomography	I:C3641875
for	O
the	O
two	O
considered	O
imaging	O
protocols	O
,	O
smaller	O
PTV	O
margins	B:C0229985
would	O
still	O
result	O
in	O
an	O
overall	O
reduction	O
in	O
secondary	O
cancer	O
risk	O
.	O

